Orchid Pharma schedules Q4 FY26 earnings call for May 26, 2026 at 4:30 PM IST hosted by Systematix Institutional Equities.
Management participants include MD Manish Dhanuka, Whole Time Director Mridul Dhanuka, and CFO Sunil Kumar Gupta.
The call will discuss financial results for Q4 and full year ended March 31, 2026, with dial-in numbers provided.
Information will be hosted on company website with no indication of UPSI sharing in the disclosure.